The Genetic Regulation of Aortic Valve Development and Calcific Disease

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2018 Nov 22

PMID 30460247

Citations 18

Authors

Vinal Menon

Joy Lincoln

Affiliations

Soon will be listed here.

Abstract

Heart valves are dynamic, highly organized structures required for unidirectional blood flow through the heart. Over an average lifetime, the valve leaflets or cusps open and close over a billion times, however in over 5 million Americans, leaflet function fails due to biomechanical insufficiency in response to wear-and-tear or pathological stimulus. Calcific aortic valve disease (CAVD) is the most common valve pathology and leads to stiffening of the cusp and narrowing of the aortic orifice leading to stenosis and insufficiency. At the cellular level, CAVD is characterized by valve endothelial cell dysfunction and osteoblast-like differentiation of valve interstitial cells. These processes are associated with dysregulation of several molecular pathways important for valve development including Notch, Sox9, Tgfβ, Bmp, Wnt, as well as additional epigenetic regulators. In this review, we discuss the multifactorial mechanisms that contribute to CAVD pathogenesis and the potential of targeting these for the development of novel, alternative therapeutics beyond surgical intervention.

Citing Articles

Algorithmic Generation of Parameterized Geometric Models of the Aortic Valve and Left Ventricle.

Pil N, Kuchumov A Sensors (Basel). 2025; 25(1.

PMID: 39796802 PMC: 11722726. DOI: 10.3390/s25010011.

Multiple cell types including melanocytes contribute to elastogenesis in the developing murine aortic valve.

Nasim S, Abujamra B, Chaparro D, da Silva Nogueira P, Riva A, Hutcheson J Sci Rep. 2024; 14(1):25481.

PMID: 39461968 PMC: 11513076. DOI: 10.1038/s41598-024-73673-5.

Implications of Bicuspid Aortic Valve Disease and Aortic Stenosis/Insufficiency as Risk Factors for Thoracic Aortic Aneurysm.

Jabagi H, Levine D, Gharibeh L, Camillo C, Castillero E, Ferrari G Rev Cardiovasc Med. 2024; 24(6):178.

PMID: 39077527 PMC: 11264121. DOI: 10.31083/j.rcm2406178.

Engineered Extracellular Vesicle-Based Therapies for Valvular Heart Disease.

Salazar-Puerta A, Kordowski M, Cuellar-Gaviria T, Rincon-Benavides M, Hussein J, Flemister D Cell Mol Bioeng. 2023; 16(4):309-324.

PMID: 37810997 PMC: 10550890. DOI: 10.1007/s12195-023-00783-x.

Exploring molecular profiles of calcification in aortic vascular smooth muscle cells and aortic valvular interstitial cells.

Kessler J, Bluemn T, DeCero S, Dutta P, Thatcher K, Mahnke D J Mol Cell Cardiol. 2023; 183:1-13.

PMID: 37579636 PMC: 10592135. DOI: 10.1016/j.yjmcc.2023.08.001.

References

Person A, Klewer S, Runyan R . Cell biology of cardiac cushion development. Int Rev Cytol. 2005; 243:287-335. DOI: 10.1016/S0074-7696(05)43005-3. View

Kokubo H, Tomita-Miyagawa S, Hamada Y, Saga Y . Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development. 2007; 134(4):747-55. DOI: 10.1242/dev.02777. View

Davies P . Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995; 75(3):519-60. PMC: 3053532. DOI: 10.1152/physrev.1995.75.3.519. View

Hutcheson J, Aikawa E, Merryman W . Potential drug targets for calcific aortic valve disease. Nat Rev Cardiol. 2014; 11(4):218-31. PMC: 4263317. DOI: 10.1038/nrcardio.2014.1. View

El-Hamamsy I, Balachandran K, Yacoub M, Stevens L, Sarathchandra P, Taylor P . Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol. 2009; 53(16):1448-55. DOI: 10.1016/j.jacc.2008.11.056. View

Wang H, Shi J, Li B, Zhou Q, Kong X, Bei Y . MicroRNA Expression Signature in Human Calcific Aortic Valve Disease. Biomed Res Int. 2017; 2017:4820275. PMC: 5405367. DOI: 10.1155/2017/4820275. View

Takahashi K, Satoh M, Takahashi Y, Osaki T, Nasu T, Tamada M . Dysregulation of ossification-related miRNAs in circulating osteogenic progenitor cells obtained from patients with aortic stenosis. Clin Sci (Lond). 2016; 130(13):1115-24. PMC: 4876482. DOI: 10.1042/CS20160094. View

Dutta P, Lincoln J . Calcific Aortic Valve Disease: a Developmental Biology Perspective. Curr Cardiol Rep. 2018; 20(4):21. PMC: 5842494. DOI: 10.1007/s11886-018-0968-9. View

OBrien K . Epidemiology and genetics of calcific aortic valve disease. J Investig Med. 2007; 55(6):284-91. DOI: 10.2310/6650.2007.00010. View

10.

Menon V, Eberth J, Junor L, Potts A, Belhaj M, DiPette D . Removing vessel constriction on the embryonic heart results in changes in valve gene expression, morphology, and hemodynamics. Dev Dyn. 2017; 247(3):531-541. PMC: 5814323. DOI: 10.1002/dvdy.24588. View

11.

Luna-Zurita L, Prados B, Grego-Bessa J, Luxan G, Del Monte G, Benguria A . Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J Clin Invest. 2010; 120(10):3493-507. PMC: 2947227. DOI: 10.1172/JCI42666. View

12.

Venkatesh D, Park K, Harrington A, Miceli-Libby L, Yoon J, Liaw L . Cardiovascular and hematopoietic defects associated with Notch1 activation in embryonic Tie2-expressing populations. Circ Res. 2008; 103(4):423-31. PMC: 2654335. DOI: 10.1161/CIRCRESAHA.108.177808. View

13.

Novaro G, Tiong I, Pearce G, Lauer M, Sprecher D, Griffin B . Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001; 104(18):2205-9. DOI: 10.1161/hc4301.098249. View

14.

Brooke B, Habashi J, Judge D, Patel N, Loeys B, Dietz 3rd H . Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med. 2008; 358(26):2787-95. PMC: 2692965. DOI: 10.1056/NEJMoa0706585. View

15.

Ortlepp J, Schmitz F, Bozoglu T, Hanrath P, Hoffmann R . Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study. Heart. 2003; 89(9):1019-22. PMC: 1767856. DOI: 10.1136/heart.89.9.1019. View

16.

Ohukainen P, Syvaranta S, Napankangas J, Rajamaki K, Taskinen P, Peltonen T . MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease. Ann Med. 2015; 47(5):423-9. DOI: 10.3109/07853890.2015.1059955. View

17.

Wirrig E, Gomez M, Hinton R, Yutzey K . COX2 inhibition reduces aortic valve calcification in vivo. Arterioscler Thromb Vasc Biol. 2015; 35(4):938-47. PMC: 4979542. DOI: 10.1161/ATVBAHA.114.305159. View

18.

Horne T, Vandekopple M, Sauls K, Koenig S, Anstine L, Garg V . Dynamic Heterogeneity of the Heart Valve Interstitial Cell Population in Mitral Valve Health and Disease. J Cardiovasc Dev Dis. 2015; 2(3):214-232. PMC: 4625550. DOI: 10.3390/jcdd2030214. View

19.

Schoen F . Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis. 1997; 6(1):1-6. View

20.

Olsen M, Wachtell K, Bella J, Liu J, Boman K, Gerdts E . Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). Am J Cardiol. 2004; 94(8):1076-80. DOI: 10.1016/j.amjcard.2004.06.074. View